Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Focal arm weakness following intradetrusor botulinum toxin administration in spinal cord injury: Report of two cases

Focal arm weakness following intradetrusor botulinum toxin administration in spinal cord injury: Report of two cases

The Journal of Spinal Cord Medicine, 2020 · DOI: 10.1080/10790268.2018.1464693 · Published: January 1, 2020

Spinal Cord InjuryUrologyRehabilitation

Simple Explanation

This report describes two cases where patients with spinal cord injuries experienced weakness in their arms after receiving botulinum toxin injections in their bladders. The arm weakness was temporary, lasting about three months, while the bladder treatment effects lasted longer. The arm weakness mainly affected the shoulder and triceps muscles. This type of localized weakness hadn't been reported before as a side effect of this bladder treatment. The researchers suggest possible reasons for this side effect, including the toxin spreading or affecting nerves in unexpected ways.

Study Duration
Not specified
Participants
Two individuals with tetraplegia
Evidence Level
Case Report

Key Findings

  • 1
    Two tetraplegic patients experienced proximal arm weakness following intradetrusor onabotulinumtoxinA administration.
  • 2
    The arm weakness lasted approximately three months, while the bladder effects persisted for over six months.
  • 3
    In one case, the proximal arm weakness recurred after repeat intradetrusor botulinum toxin injection.

Research Summary

This report presents two cases of tetraplegic individuals who developed proximal arm weakness temporally related to intradetrusor onabotulinumtoxinA administration without systemic effects. The arm weakness lasted about three months in both cases, while the bladder effects persisted for over six months. In one case, the weakness recurred after repeat injection. The cases represent a previously unreported phenomenon of proximal focal weakness associated with intradetrusor chemodenervation, and possible mechanisms are discussed.

Practical Implications

Recognize Focal Weakness

Clinicians should recognize focal weakness as a possible side effect of botulinum toxin therapy.

Consider Alternative Explanations

Avoid unnecessary procedures by considering botulinum toxin as a potential cause of focal weakness.

Patient Education

Patients should be informed about the possibility of distant and focal paretic symptoms following intradetrusor botulinum toxin administration.

Study Limitations

  • 1
    [object Object]
  • 2
    [object Object]
  • 3
    [object Object]

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury